Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $8.20 billion. The enterprise value is $8.03 billion.
Market Cap | 8.20B |
Enterprise Value | 8.03B |
Important Dates
The next confirmed earnings date is Wednesday, July 24, 2024, after market close.
Earnings Date | Jul 24, 2024 |
Ex-Dividend Date | May 30, 2024 |
Share Statistics
Chemed has 15.14 million shares outstanding. The number of shares has increased by 1.52% in one year.
Shares Outstanding | 15.14M |
Shares Change (YoY) | +1.52% |
Shares Change (QoQ) | +0.48% |
Owned by Insiders (%) | 2.16% |
Owned by Institutions (%) | 97.32% |
Float | 14.81M |
Valuation Ratios
The trailing PE ratio is 29.14 and the forward PE ratio is 22.49. Chemed's PEG ratio is 2.63.
PE Ratio | 29.14 |
Forward PE | 22.49 |
PS Ratio | 3.58 |
Forward PS | 3.28 |
PB Ratio | 6.93 |
P/FCF Ratio | 27.07 |
PEG Ratio | 2.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.79, with an EV/FCF ratio of 26.52.
EV / Earnings | 28.35 |
EV / Sales | 3.50 |
EV / EBITDA | 18.79 |
EV / EBIT | 21.97 |
EV / FCF | 26.52 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.12.
Current Ratio | 1.91 |
Quick Ratio | 1.74 |
Debt / Equity | 0.12 |
Debt / EBITDA | 0.34 |
Debt / FCF | 0.48 |
Interest Coverage | 184.49 |
Financial Efficiency
Return on equity (ROE) is 26.60% and return on invested capital (ROIC) is 19.93%.
Return on Equity (ROE) | 26.60% |
Return on Assets (ROA) | 17.50% |
Return on Capital (ROIC) | 19.93% |
Revenue Per Employee | $152,018 |
Profits Per Employee | $18,785 |
Employee Count | 15,087 |
Asset Turnover | 1.42 |
Inventory Turnover | 138.48 |
Taxes
In the past 12 months, Chemed has paid $80.28 million in taxes.
Income Tax | 80.28M |
Effective Tax Rate | 22.07% |
Stock Price Statistics
The stock price has increased by +0.52% in the last 52 weeks. The beta is 0.46, so Chemed's price volatility has been lower than the market average.
Beta (5Y) | 0.46 |
52-Week Price Change | +0.52% |
50-Day Moving Average | 557.25 |
200-Day Moving Average | 575.70 |
Relative Strength Index (RSI) | 44.33 |
Average Volume (20 Days) | 95,913 |
Short Selling Information
The latest short interest is 280,942, so 1.86% of the outstanding shares have been sold short.
Short Interest | 280,942 |
Short Previous Month | 303,470 |
Short % of Shares Out | 1.86% |
Short % of Float | 1.90% |
Short Ratio (days to cover) | 3.59 |
Income Statement
In the last 12 months, Chemed had revenue of $2.29 billion and earned $283.41 million in profits. Earnings per share was $18.59.
Revenue | 2.29B |
Gross Profit | 813.47M |
Operating Income | 340.08M |
Pretax Income | 363.69M |
Net Income | 283.41M |
EBITDA | 427.54M |
EBIT | 365.67M |
Earnings Per Share (EPS) | $18.59 |
Balance Sheet
The company has $313.35 million in cash and $146.14 million in debt, giving a net cash position of $167.21 million or $11.04 per share.
Cash & Cash Equivalents | 313.35M |
Total Debt | 146.14M |
Net Cash | 167.21M |
Net Cash Per Share | $11.04 |
Equity (Book Value) | 1.18B |
Book Value Per Share | 78.17 |
Working Capital | 257.64M |
Cash Flow
In the last 12 months, operating cash flow was $354.36 million and capital expenditures -$51.42 million, giving a free cash flow of $302.94 million.
Operating Cash Flow | 354.36M |
Capital Expenditures | -51.42M |
Free Cash Flow | 302.94M |
FCF Per Share | $20.03 |
Margins
Gross margin is 35.47%, with operating and profit margins of 14.83% and 12.36%.
Gross Margin | 35.47% |
Operating Margin | 14.83% |
Pretax Margin | 15.86% |
Profit Margin | 12.36% |
EBITDA Margin | 18.64% |
EBIT Margin | 15.94% |
FCF Margin | 13.21% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 0.30%.
Dividend Per Share | $1.60 |
Dividend Yield | 0.30% |
Dividend Growth (YoY) | 5.26% |
Years of Dividend Growth | 15 |
Payout Ratio | 8.61% |
Buyback Yield | -1.52% |
Shareholder Yield | -1.22% |
Earnings Yield | 3.46% |
FCF Yield | 3.69% |
Analyst Forecast
The average price target for Chemed is $673.50, which is 24.34% higher than the current price. The consensus rating is "Buy".
Price Target | $673.50 |
Price Target Difference | 24.34% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
Last Split Date | May 12, 2005 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 13.28 and a Piotroski F-Score of 7.
Altman Z-Score | 13.28 |
Piotroski F-Score | 7 |